PHARMACAPS
Table of contents:
The "PHARMACAPS" trademark, serial number 77721772 , was filed on 24th of April 2009 with a mark drawing code of 4000 and its transaction date is 77721772. The attorney assigned is Maury M. Tepper, III, attorney docket number 04700.1.4. Since 1st of May 2014, the document can be found in the M20 law office in the publication and issue section. The employee responsible is WHITTAKER BROWN, TRACY and the date it was published for opposition on 05/11/2010. The status of this trademark was checked last on 08/05/2013.
Prior registrations: 1934884
The corresponded responsible for this trademark is Maury M. Tepper, III, located at Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609.The state or country where the trademark was organized is NC by Banner Pharmacaps Inc.. The legal entity type behing it is a Corporation, located at 4125 Premier Drive, High Point, NC zip 27265.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 04/28/2009 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | soft gelatin and non-animal film encapsulations and hard core enrobements for various pharmaceutical preparations, namely, aids related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; soft gelatin and non-animal film encapsulations and hard core enrobements for cardiovascular agents, namely, calcium channel blockers for heart disease; soft gelatin and non-animal film encapsulations and hard core enrobements for gastrointestinal preparations, namely, preparations for the treatment of flatulence and constipation; soft gelatin and non-animal film encapsulations and hard core enrobements for musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; soft gelatin and non-animal film encapsulations and hard core enrobements for transplant and immunosuppressant preparations, namely, cyclosporine; soft gelatin and non-animal film encapsulations and hard core enrobements for pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; soft gelatin and non-animal film encapsulations and hard core enrobements for natural medicine preparations, namely, herbal supplements; soft gelatin and non-animal film encapsulations and hard core enrobements for vitamin, mineral and nutritional supplements; pharmaceutical preparations, namely, AIDS related complex (ARC) therapeutic agents, antidiarrheals, antihistamines, analgesics, antacids, antiflatulents, antifungals, antiemetics, antipyretics, antiarthritics, antiinfectives for the treatment of fungal and viral infections, antinauseants, antiobesity preparations, cancer therapy preparations, calcium supplements, cough and cold preparations, digestants, diuretics, dermatologicals for the treatment of skin disorders, hormones, histamine H2 receptor antagonists, hypnotics, hypolipidemics, laxatives, psychotherapeutics, sedatives and sleep aids; cardiovascular agents, namely, calcium channel blockers for heart disease; gastrointestinal products, namely, preparations for the treatment of flatulence and constipation; musculoskeletal preparations, namely, calcium, vitamin D and osteoporosis treatments; transplant and immunosuppressant preparations, namely, cyclosporine; pharmaceutical preparations for the treatment of disorders of the central nervous system, the respiratory system, for the treatment of sexual dysfunction and for the treatment of neurological disorders and seizures; natural medicine products, namely, herbal supplements; vitamin, mineral and nutritional supplements |
| PM0000 | PHARMA CAPS; PHARMACEUTICAL ENCAPSULATIONS |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 04/30/2014 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 08/05/2013 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
| 08/05/2013 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
| 12/27/2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 12/26/2012 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 12/26/2012 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
| 12/20/2012 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
| 12/20/2012 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 07/07/2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 07/06/2012 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
| 07/03/2012 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
| 07/03/2012 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 01/12/2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 01/11/2012 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
| 01/04/2012 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
| 01/04/2012 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 07/12/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 07/11/2011 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
| 07/06/2011 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
| 07/07/2011 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 07/06/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 01/06/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 01/04/2011 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
| 01/04/2011 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
| 01/04/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 07/06/2010 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
| 05/11/2010 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
| 05/11/2010 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 04/07/2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 04/07/2010 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 03/20/2010 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 03/19/2010 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
| 03/19/2010 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEN | |
| 03/19/2010 | EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEA - EXAMINERS AMENDMENT E-MAILED | |
| 03/19/2010 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
| 12/30/2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 12/30/2009 | NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRT - NON-FINAL ACTION E-MAILED | |
| 12/30/2009 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 12/01/2009 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 12/01/2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 12/01/2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 11/23/2009 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 11/23/2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 11/23/2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 07/11/2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 07/11/2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 07/11/2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 07/11/2009 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 07/11/2009 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 07/07/2009 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 04/29/2009 | NOTICE OF PSEUDO MARK MAILED | O - Outgoing Correspondence | MPMK | |
| 04/28/2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 04/28/2009 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "PHARMACAPS" trademark, serial number 86006722 , was filed on 10th of July 2013 with a mark drawing code of 4000 and its transaction date is 86006722. Since 15th of May 2014, the document can be found in the L90 law office in the publication and issue section. The employee responsible is MARCY, AMY ALFIERI and the date it was published for opposition on 10/29/2013. The status of this trademark was checked last on 05/13/2014.
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.